Clinical trial

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

NCT01769066

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-12-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2009-12-01Date precision: month

Registry last updated2016-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Interventions

Sequential Gefitinib With Pemetrexed/PlatinumDRUG

Pemetrexed/PlatinumDRUG

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01769066 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.